share_log

HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $9

HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $9

HC Wainwright & Co.維持對Ekso Bionics Holdings的買入,將目標股價下調至9美元
Benzinga Real-time News ·  2022/07/29 06:24

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $11 to $9.

HC Wainwright&Co.分析師Swayampakula Ramakanth維持Ekso Bionics Holdings(納斯達克代碼:EKSO)的買入,並將目標價從11美元下調至9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論